May 26, 2016

Marrone Bio Innovations Announces Agreement to Settle Class Action Litigation

DAVIS, Calif.--(BUSINESS WIRE)-- Marrone Bio Innovations, Inc. (the "Company") (NASDAQ:MBII), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, today announced the Company and other defendants, including certain of the Company's current and former officers and directors, have reached an agreement to settle the private securities class action litigation consolidated in the U.S. District Court for the Eastern District of California on February 13, 2015 as Special Situations Fund III QP, L.P. et al v. Marrone Bio Innovations, Inc. et al, Case No 2:14-cv-02571-MCE-KJN. The agreement is subject to review and approval by the court after notice and an opportunity to object are provided to the plaintiff class. The settlement agreement contains no admission or concession of wrongdoing or liability by the Company or any other defendant and includes a full release of claims. The agreement provides for a settlement payment to the class of $12,000,000, which will be paid by insurance carriers. Accordingly, the settlement of these lawsuits will have no adverse impact on the Company's financial position or operations.

About Marrone Bio Innovations

About Marrone Bio Innovations Smart. Natural. Solutions. Marrone Bio Innovations, Inc. (MBII) aims to lead the movement to a more sustainable world through the discovery, development and promotion of biological products for pest management and plant health. Our effective and environmentally responsible solutions help customers operate more sustainably while controlling pests, improving plant health, and increasing crop yields. We have four products for agriculture on the market (Regalia, Grandevo®, Venerate® and Majestene®), a proprietary discovery process, a rapid development platform, and a robust pipeline of pest management and plant health product candidates. At Marrone Bio Innovations we are dedicated to pioneering better biopesticides that support a better tomorrow for users around the globe. For more information, please visit www.marronebio.com.

Forward Looking Statements

This press release contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts, included in this press release regarding our strategy, future operations and plans, including assumptions underlying such statements, are forward-looking statements, and should not be relied upon as representing our views as of any subsequent date. Examples of such statements include statements regarding the terms, Court approval and financial impact of the settlement. Such forward-looking statements are based on information available to the Company as of the date of this release and involve a number of risks and uncertainties, some beyond the Company's control, that could cause actual results to differ materially from those anticipated by these forward-looking statements, including failure of the Court to approve the settlement terms. Additional information that could lead to material changes in the Company's performance is contained in its filings with the SEC. We are under no obligation to, and expressly disclaim any responsibility to, update or alter forward-looking statements contained in this release, whether as a result of new information, future events or otherwise.

Investors
ICR
James Palczynski, +1-203-682-8229
ir@marronebio.com

Source: Marrone Bio Innovations, Inc.

News Provided by Acquire Media


Close window | Back to top

Copyright 2017 Marrone Bio Innovations